ALFREDO RIVIÈRE is founder of the SURAL Group–more than a half-dozen companies with operations on four continents. SURAL subsidiaries fabricate aluminum parts for the automobile and electronics industries, produce synthetic quartz used as timing devices in clocks and dozens of household items, and manufacture electronic chips for cell phones and other sophisticated applications. Dr. Rivière, who went to MIT citation generator for his graduate studies in electrical engineering and industrial management, holds nearly 50 patents.
Mrs. NORMA RIVIÈRE supported the work of Hopkins physician Paul Ladenson in studying the Yanomami Indians, a Venezuelan tribe with an unusual thyroid condition. She and her husband have generously supported thyroid-related research in South America, as well as programs to eliminate iodine deficiency in Venezuela.
Held by Gary S. Wand
GARY S. WAND, MD is The Alfredo Rivière and Norma Rodriguez de Rivière Professor in Endocrinology and Metabolism, and a Professor of Psychiatry. Dr. Wand received his Internal Medicine training and his medical degree from George Washington University. After completing his post-doctoral training in Endocrinology and Metabolism in 1986 at Johns Hopkins, he joined the School of Medicine faculty in the department of Medicine and has been a leader at the institution ever since.
As an internationally recognized pituitary specialist and Director of the Neuroendocrine Service within the Division of Endocrinology, Diabetes and Metabolism, Dr. Wand works as a researcher, educator and clinician. He is the recipient of local and national “Best Doctor” awards. He was the first chairperson of the Department of Medicine’s Diversity Council and was instrumental in promoting the recruitment of under-represented minorities into residency and fellowship programs as well as onto faculty. In recognition of these efforts, Dr. Wand received Johns Hopkins’ highest honor in this area, the Diversity Recognition Award.
Recognized internationally for his scientific contributions, Dr. Wand is a recipient of a Merit award from the National Institutes of Health (NIH), placing him above the 95th percentile of the distribution of NIH grants over the last 25 years. He has been elected to the Association of American Physicians and the American College of Neuropsychopharmacology and is author of more than 160 articles and chapters. Dr. Wand conducts both basic and clinical research in neuropsychiatric disorders employing interdisciplinary techniques from the fields of genetics, neuroendocrinology, behavior, and neuropharmacology.
Dr. Wand’s research has advanced understanding of the genetic and environmental determinants of the stress response and has elucidated how excessive stress hormone production may contribute to neurobiological conditions such as alcohol or drug disorders. In March 2015, Dr. Wand was specially selected by The National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the NIH, as the 7th Annual Jack Mendelson Honorary Lecturer. The title of his presentation was “Cortisol Dysregulation and Alcoholism: Consequence, Correlation or Causality?”